Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Esthetic Products International (EPI) is a biotechnology company specializing in advanced hair and scalp science. The company is the developer and owner of the QR678® platform technology, a patented, first-in-class formulation of growth factors designed to treat various forms of hair loss. QR678 has received composition patents in both the United States and India and is supported by extensive clinical research published in peer-reviewed journals. EPI's products are utilized globally in dermatology and plastic surgery clinics for indications such as androgenetic alopecia and alopecia areata. The company was co-founded by renowned facial plastic surgeon Dr. Debraj Shome and cosmetic dermatologist Dr. Rinky Kapoor. Headquartered in Sofia, Bulgaria, with significant operations in India, EPI continues to expand its portfolio of regenerative aesthetic solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Esthetic Products International.